ZENTALIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.77 USD | -6.36% |
|
-7.40% | -22.31% |
| Apr. 11 | Zentalis Pharmaceuticals, Inc. Announces Executive Changes | CI |
| Apr. 11 | Zentalis Pharmaceuticals, Inc. Announces CFO Changes | CI |
Chart calendar Zentalis Pharmaceuticals, Inc.
33cecc58d4b15b71b2e9ba9ee85d.GzLfRBKn0GD8eecqruh-ghKG7DTuq7KkR8nR7fVXKeI.TX6PdXnQkQayVNZa5sU5y0HWo3CW-4reJJmfuaoHBIoqao4Vav7pWdEhkA~5c9b9e3a8f61a57bfd5d3fd41c0f4bd9
Upcoming events on Zentalis Pharmaceuticals, Inc.
Past events on Zentalis Pharmaceuticals, Inc.
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract Number: 6487 |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-11 03:20 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2024-02-27 07:00 am | Q4 2023 Earnings Release |
| 2024-02-14 12:40 pm | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
| 2023-11-15 03:30 am | Jefferies London Healthcare Conference |
| 2023-11-10 10:00 am | Investor Meeting - Key Opinion Leader |
| 2023-11-06 07:18 am | Q3 2023 Earnings Release |
| 2023-09-13 10:10 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-09 07:00 am | Q2 2023 Earnings Release |
| 2023-06-16 09:30 am | Annual General Meeting |
| 2023-06-06 08:00 am | American Society of Clinical Oncology Meeting |
| 2023-06-05 05:30 pm | American Society of Clinical Oncology Conference - Abstract Number:5513 |
| 2023-06-05 02:15 pm | American Society of Clinical Oncology Conference |
| 2023-05-10 07:00 am | Q1 2023 Earnings Release |
| 2023-04-17 01:30 pm | American Association for Cancer Research Meeting - Abstract No: 2796 |
| 2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No - 2153 |
| 2023-03-01 07:00 am | Q4 2022 Earnings Release |
| 2023-02-14 03:00 pm | SVB Securities Global Biopharma Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 7,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -119 -118 -0.2% | -216 -235 7.97% | -226 -230 1.98% | -298 -269 -10.63% | -257 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -119 -116 -2.36% | -217 -233 7.22% | -227 -236 3.81% | -300 -291 -3.02% | -274 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -118 -115 -2.65% | -165 -167 1.21% | -221 -238 7.06% | -277 -280 0.99% | -264 |
|
Net income Million USD | Released Forecast Spread | -46,4 | -119 -114 -3.68% | -159 -174 8.59% | -237 -239 0.92% | -292 -291 -0.43% | -270 |
|
EPS USD | Released Forecast Spread | -8,16 | -4,19 -4,88 14.1% | -3,72 -4,01 7.34% | -4,48 -4,58 2.15% | -4,47 -4,53 1.43% | -3,64 |
| Announcement Date | 06/03/20 | 25/03/21 | 24/02/22 | 01/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 11,7 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -48,0 -69,2 30.62% | -51,4 -55,0 6.51% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -48,2 -65,6 26.48% | -57,9 -55,0 -5.22% | -63,5 -58,2 -9.11% | -54,2 -63,0 13.91% | -51,8 -61,6 15.98% | -65,0 -56,2 -15.66% | -104 -63,2 -64.44% | -62,7 -62,3 -0.75% | -67,9 -64,0 -6.13% | -55,6 | -70,5 | -72,3 | -75,6 | -71,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,1 -54,1 11.1% | -57,5 -55,4 -3.8% | -63,0 -55,5 -13.49% | -52,3 -60,8 14% | -48,5 -63,5 23.59% | -60,8 -56,5 -7.74% | -99,5 -62,5 -59.04% | -55,5 -59,9 7.32% | -61,1 -59,2 -3.17% | -53,1 | -66,9 | -69,4 | -74,2 | |
|
Net income Million USD | Released Forecast Spread | -50,1 -58,2 13.96% | -59,1 -54,4 -8.59% | -68,4 -57,0 -19.91% | -54,4 -62,1 12.46% | -55,0 -61,9 11.18% | -63,2 -55,9 -13.19% | -113 -63,0 -78.62% | -55,5 -63,8 12.9% | -60,9 -61,5 0.96% | -56,7 | -68,0 | -70,9 | -74,9 | |
|
EPS USD | Released Forecast Spread | -1,11 -1,33 16.37% | -1,31 -1,21 -8.66% | -1,34 -1,19 -12.2% | -0,96 -1,21 20.55% | -0,92 -1,06 13.39% | -1,07 -1,02 -4.9% | -1,85 -1,04 -78.16% | -0,79 -0,94 16.32% | -0,83 -0,90 7.49% | -0,75 | -0,94 | -0,98 | -0,99 | -0,79 |
| Announcement Date | 24/02/22 | 05/05/22 | 09/08/22 | 09/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 06/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Zentalis Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZNTL Stock
- Calendar Zentalis Pharmaceuticals, Inc.
